Validation of datascope accutorr plus [trade mark sign] using British hypertension society [BHS] and association for the advancement of medical instrumentation [AAMI] protocol guidelines

To assure the accuracy and reliability of blood pressure measurement by non-invasive blood pressure monitor using Datascope Accutorr Plus[trade mark sign] [Paramus, NJ,USA] against mercury manometer, among adult male participants. Eighty participants from a family physician's office at a teaching hospital were recruited. One hundred and sixty measurements of blood pressure were performed according to BHS technique protocol. Descriptive analysis was done according to the AAMI and BHS protocol guidelines. The limits of agreement between the device and the standard were plotted using the method of Bland and Altman plot. The mean difference +/- SD between the Datascope Acutorr Plus[trade mark sign] and observer was 2.7 +/- 5.2 mm Hg and 1.5 +/- 3.26 mm Hg for systolic and diastolic blood pressure, respectively. Datascope Acutorr Plus [trade mark sign] obtained A/A grading for both systolic and diastolic blood pressure. Datascope Accutorr Plus [trade mark sign] [Paramus, NJ, USA] satisfies BHS and AAMI validation protocols for both systolic and diastolic BP and may be recommended for everyday use for BP monitoring at home and in clinical use for adult population